Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

NYSE:KRO - New York Stock Exchange, Inc. - US50105F1057 - Common Stock - Currency: USD

9.59  -0.15 (-1.54%)

After market: 9.59 0 (0%)

Fundamental Rating

5

Overall KRO gets a fundamental rating of 5 out of 10. We evaluated KRO against 84 industry peers in the Chemicals industry. KRO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KRO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

KRO had positive earnings in the past year.
KRO had a positive operating cash flow in the past year.
Of the past 5 years KRO 4 years were profitable.
KRO had a positive operating cash flow in each of the past 5 years.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

KRO has a Return On Assets of 4.90%. This is in the better half of the industry: KRO outperforms 73.17% of its industry peers.
KRO has a Return On Equity of 11.10%. This is in the better half of the industry: KRO outperforms 73.17% of its industry peers.
The Return On Invested Capital of KRO (4.45%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.9%
ROE 11.1%
ROIC 4.45%
ROA(3y)2.78%
ROA(5y)3.18%
ROE(3y)5.94%
ROE(5y)7.3%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

1.3 Margins

KRO's Profit Margin of 5.05% is in line compared to the rest of the industry. KRO outperforms 59.76% of its industry peers.
KRO has a Operating Margin of 4.66%. This is in the lower half of the industry: KRO underperforms 67.07% of its industry peers.
Looking at the Gross Margin, with a value of 17.62%, KRO is doing worse than 69.51% of the companies in the same industry.
In the last couple of years the Gross Margin of KRO has declined.
Industry RankSector Rank
OM 4.66%
PM (TTM) 5.05%
GM 17.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.71%
GM growth 5Y-21.8%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KRO is destroying value.
Compared to 1 year ago, KRO has less shares outstanding
Compared to 5 years ago, KRO has less shares outstanding
The debt/assets ratio for KRO is higher compared to a year ago.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

KRO has an Altman-Z score of 2.02. This is not the best score and indicates that KRO is in the grey zone with still only limited risk for bankruptcy at the moment.
KRO has a Altman-Z score of 2.02. This is comparable to the rest of the industry: KRO outperforms 57.32% of its industry peers.
KRO has a debt to FCF ratio of 8.51. This is a slightly negative value and a sign of low solvency as KRO would need 8.51 years to pay back of all of its debts.
KRO's Debt to FCF ratio of 8.51 is in line compared to the rest of the industry. KRO outperforms 53.66% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that KRO is somewhat dependend on debt financing.
KRO's Debt to Equity ratio of 0.56 is in line compared to the rest of the industry. KRO outperforms 54.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.51
Altman-Z 2.02
ROIC/WACC0.55
WACC8.05%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

KRO has a Current Ratio of 2.68. This indicates that KRO is financially healthy and has no problem in meeting its short term obligations.
KRO's Current ratio of 2.68 is fine compared to the rest of the industry. KRO outperforms 71.95% of its industry peers.
KRO has a Quick Ratio of 1.30. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, KRO is in line with its industry, outperforming 47.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 1.3
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 144.64% over the past year.
Looking at the last year, KRO shows a quite strong growth in Revenue. The Revenue has grown by 15.87% in the last year.
Measured over the past years, KRO shows a small growth in Revenue. The Revenue has been growing by 0.06% on average per year.
EPS 1Y (TTM)144.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)15.87%
Revenue growth 3Y0.56%
Revenue growth 5Y0.06%
Sales Q2Q%22.12%

3.2 Future

The Earnings Per Share is expected to grow by 66.59% on average over the next years. This is a very strong growth
Based on estimates for the next years, KRO will show a quite strong growth in Revenue. The Revenue will grow by 12.13% on average per year.
EPS Next Y239.91%
EPS Next 2Y99.4%
EPS Next 3Y66.59%
EPS Next 5YN/A
Revenue Next Year24.1%
Revenue Next 2Y14.98%
Revenue Next 3Y12.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

KRO is valuated quite expensively with a Price/Earnings ratio of 38.36.
67.07% of the companies in the same industry are cheaper than KRO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.46. KRO is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 11.29, the valuation of KRO can be described as very reasonable.
78.05% of the companies in the same industry are more expensive than KRO, based on the Price/Forward Earnings ratio.
KRO is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.36
Fwd PE 11.29
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KRO is on the same level as its industry peers.
67.07% of the companies in the same industry are more expensive than KRO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.95
EV/EBITDA 10.88
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KRO's earnings are expected to grow with 66.59% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y99.4%
EPS Next 3Y66.59%

6

5. Dividend

5.1 Amount

KRO has a Yearly Dividend Yield of 1.99%.
KRO's Dividend Yield is a higher than the industry average which is at 3.22.
Compared to an average S&P500 Dividend Yield of 2.27, KRO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

The dividend of KRO has a limited annual growth rate of 2.22%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
KRO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.22%
Div Incr Years0
Div Non Decr Years13
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

KRO pays out 75.88% of its income as dividend. This is not a sustainable payout ratio.
KRO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP75.88%
EPS Next 2Y99.4%
EPS Next 3Y66.59%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (1/31/2025, 8:04:00 PM)

After market: 9.59 0 (0%)

9.59

-0.15 (-1.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners14.66%
Inst Owner Change-0.08%
Ins Owners0.11%
Ins Owner Change0%
Market Cap1.10B
Analysts46
Price Target12.24 (27.63%)
Short Float %2.74%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend0.76
Dividend Growth(5Y)2.22%
DP75.88%
Div Incr Years0
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.32%
Min EPS beat(2)-76.11%
Max EPS beat(2)11.47%
EPS beat(4)3
Avg EPS beat(4)191.6%
Min EPS beat(4)-76.11%
Max EPS beat(4)766.34%
EPS beat(8)3
Avg EPS beat(8)3.44%
EPS beat(12)6
Avg EPS beat(12)13.68%
EPS beat(16)8
Avg EPS beat(16)12.45%
Revenue beat(2)0
Avg Revenue beat(2)-12.25%
Min Revenue beat(2)-15.74%
Max Revenue beat(2)-8.76%
Revenue beat(4)2
Avg Revenue beat(4)-4.23%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)4.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.15%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 38.36
Fwd PE 11.29
P/S 0.59
P/FCF 16.95
P/OCF 12.59
P/B 1.3
P/tB 1.31
EV/EBITDA 10.88
EPS(TTM)0.25
EY2.61%
EPS(NY)0.85
Fwd EY8.86%
FCF(TTM)0.57
FCFY5.9%
OCF(TTM)0.76
OCFY7.94%
SpS16.2
BVpS7.37
TBVpS7.34
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.9%
ROE 11.1%
ROCE 5.7%
ROIC 4.45%
ROICexc 4.75%
ROICexgc 4.76%
OM 4.66%
PM (TTM) 5.05%
GM 17.62%
FCFM 3.49%
ROA(3y)2.78%
ROA(5y)3.18%
ROE(3y)5.94%
ROE(5y)7.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.71%
GM growth 5Y-21.8%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 8.51
Debt/EBITDA 3.24
Cap/Depr 38.59%
Cap/Sales 1.21%
Interest Coverage 2.73
Cash Conversion 60.33%
Profit Quality 69.18%
Current Ratio 2.68
Quick Ratio 1.3
Altman-Z 2.02
F-Score6
WACC8.05%
ROIC/WACC0.55
Cap/Depr(3y)111.34%
Cap/Depr(5y)111.33%
Cap/Sales(3y)3.05%
Cap/Sales(5y)3.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y239.91%
EPS Next 2Y99.4%
EPS Next 3Y66.59%
EPS Next 5YN/A
Revenue 1Y (TTM)15.87%
Revenue growth 3Y0.56%
Revenue growth 5Y0.06%
Sales Q2Q%22.12%
Revenue Next Year24.1%
Revenue Next 2Y14.98%
Revenue Next 3Y12.13%
Revenue Next 5YN/A
EBIT growth 1Y221.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year404.32%
EBIT Next 3Y84.76%
EBIT Next 5YN/A
FCF growth 1Y-10.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.25%
OCF growth 3Y-62.28%
OCF growth 5Y-50.68%